Novavax (NVAX) Misses Q2 EPS by $12.03, Cuts FY Guidance
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $9.00 --0%
EPS Growth %: -164.5%
Financial Fact:
Revenue: 102K
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -164.5%
Financial Fact:
Revenue: 102K
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q2 EPS of ($6.53), $12.03 worse than the analyst estimate of $5.50. Revenue for the quarter came in at $186 billion versus the consensus estimate of $1.02 billion.
GUIDANCE:
Novavax sees FY2022 revenue of $2-2.3 billion, versus the consensus of $4.27 billion.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot Guidance, Trading HaltsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
